BP
ABBV icon

BNP Paribas’s AbbVie ABBV Stock Holding History

BNP Paribas’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20M Buy
79,596
+11,318
+17% +$2.44M 0.54% 32
2026
Q1 		$14.9M Sell
68,278
-9,992
-13% -$2.22M 0.47% 45
2025
Q4 		$17.9M Buy
78,270
+30,139
+63% +$6.87M 0.51% 38
2025
Q3 		$11.1M Buy
48,131
+11
+0% +$2.24K 0.34% 55
2025
Q2 		$8.93M Buy
48,120
+338
+0.7% +$62.8K 0.29% 68
2025
Q1 		$10M Sell
47,782
-33
-0.1% -$6.42K 0.41% 58
2024
Q4 		$8.49M Buy
47,815
+1,755
+4% +$323K 0.05% 59
2024
Q3 		$9.09M Sell
46,060
-1,430
-3% -$267K 0.38% 53
2024
Q2 		$8.15M Sell
47,490
-3,780
-7% -$626K 0.41% 52
2024
Q1 		$9.33M Buy
+51,270
New +$8.84M 0.44% 52

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas's ABBV Position: Q2 2026 in Review

BNP Paribas increased its AbbVie (ABBV) stake by 17% in Q2 2026, buying an estimated $2.44M and bringing the position to 79,596 shares worth $20M. The position accounts for 0.54% of the portfolio, ranked #32.

BNP Paribas first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • BNP Paribas held 79,596 shares of AbbVie worth $20M as of Q2 2026.
  • BNP Paribas bought 11,318 AbbVie shares in Q2 2026, an estimated $2.44M.
  • AbbVie made up 0.54% of BNP Paribas's portfolio in Q2 2026, its #32 holding.
  • BNP Paribas first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.